Paradeep Phosphates (PARADEEP) Q4 21/22 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 21/22 earnings summary
2 Nov, 2026Executive summary
FY22 delivered strong growth in revenue and profit on higher fertilizer volumes; elevated input costs compressed EBITDA margin despite stronger gross profit.
Goa fertilizer plant acquisition, completed June 1, 2022, expanded the product portfolio and market reach; IPO listing in May 2022 marked the transition to fully private ownership.
Financial highlights
Consolidated operating revenue rose 52.2% YoY to ₹7,858.72 crore; PAT increased 78.5% to ₹398.45 crore and PBT increased 46% to ₹534.99 crore.
EBITDA reached ₹710.38 crore, up 26.5% YoY; EBITDA margin fell to 9.0% from 10.9% as raw material costs rose.
Production increased 22% to 1,247,178 MT; manufactured-product sales rose 10.79%, while traded-product sales declined 47.77%.
Finance costs declined 23.2% to ₹85.54 crore, supported by repayment of long-term borrowings and lower short-term borrowings.
Outlook and guidance
Priority is integrating the Goa plant, realizing synergies, improving cost efficiency and productivity, expanding geographic reach, and strengthening brand value.
Paradeep DAP/NPK granulation capacity was being raised to 1.8 million MT, with completion targeted for October 2022; phosphoric acid capacity was planned to rise from 0.30 million MT to 0.50 million MT by FY23.
Management expected Paradeep expansion projects to support revenue and shareholder value and anticipated favorable prospects in the coming years.
Latest events from Paradeep Phosphates
- Profit improved as production volumes fell and working-capital needs drove operating cash outflow.PARADEEP
Q4 18/19 - Lower tax lifted FY20 profit despite weaker revenue and production.PARADEEP
Q4 19/20 - Higher earnings and lower finance costs accompanied a proposed US$280 million Goa acquisition.PARADEEP
Q4 20/21 - Capacity reached 3 MMTPA as revenue surged, while profit and returns fell.PARADEEP
Q4 22/23 - H1 revenue grew, but weaker profits and volumes left debt reduction reliant on Rabi sales.PARADEEP
Q2 26/27 - Revenue up 36% YoY, EBITDA up 25%, with strong DAP sales and MCFL merger boosting growth.PARADEEP
Q1 26/27 - Strong growth in revenue, profit, and volumes, boosted by MCFL merger and expansion projects.PARADEEP
Q3 25/26 - Q1 FY26 revenue up 58% YoY, EBITDA nearly doubled, and MCFL merger nears completion.PARADEEP
Q1 25/26 - Net profit up 134.7% YoY in H1 FY26, driven by MCFL merger and major capacity expansion.PARADEEP
Q2 25/26